Results

Total Results: 1,187 records

Showing results for "weeks".

261. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - After 24 weeks, the device was removed from patients in the treatment group. … 31.8%±21.3% and in the control group was 18.3%±20.9% (p=0.1371).6 The authors reported that at 48 weeks … , which was 24 weeks after device removal, patients treated with ReShape 3 Duo maintained 64% … After 56 weeks, patients discontinued treatment and were observed for an additional 12 weeks.56 A company … At 56 weeks, 69% of the prediabetes subgroup treated with liraglutide 3 mg no longer showed signs

262. September 2021 Surveillance Report 1: Comparative Effectiveness Review No. 250: Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-other-plant-based-treatments-surveillance-report-1-updated_0.PDF
     December 01, 2021 - through August 2, 2021 databases monthly, for studies of patients with chronic pain for at least 4 weeks

263. Progestogens for the Prevention of Preterm Birth | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/progestogens-preterm-birth/research-protocol

264. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_2012-12-11.pdf
     January 01, 2012 - mimic the effects of GI bypass surgery. 23 The device is intended to remain in place for 12–24 weeks … implantation was successful in 26 of 30 patients; however, the device was removed from 4 patients after 12 weeks … results of a study of 17 patients who were obese and had T2DM who received the EndoBarrier for 24 weeks

265. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
     May 01, 2006 - fixed-dose epoetin administered weekly vs. thrice weekly; fixed dose epoetin administered weekly vs. every 3 weeks

266. FRN 22: Future Research Needs for Strategies To Reduce Cesarean Birth in Low-Risk Women (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cesarean-birth_research.pdf
     January 01, 2020 - Does elective induction at 39 weeks vs. expectant management at 39 weeks influence use of cesarean? … Does elective induction at 39 weeks vs. expectant management at 39 weeks influence use of cesarean? … 95 Does elective induction at 39 weeks vs. expectant management at 39 weeks influence use of cesarean … 36 34 30 28 32 31 31 222 Middle Does elective induction at 39 weeks vs. expectant management at 39 weeks …   Middle Does elective induction at 39 weeks vs. expectant management at 39 weeks influence use

267. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/14_substanceabuse_potential_high_impact_june_2012.pdf
     January 01, 2012 - participants who were smokers, the study authors reported that 14.3% of the participants quit smoking at 4 weeks … . 5 The trial is expected to enroll 500 participants, and to gather followup cessation data at 6 weeks … problems of low adherence and medication diversion because the drugs’ effects may last for several weeks … extended-release naltrexone for this indication is intended to be dosed at 380 mg intramuscularly every 4 weeks

268. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
     July 01, 2013 - After 24 weeks, the device was removed from patients in the treatment group. … , which was 24 weeks after device removal, patients treated with ReShape 8 Duo maintained 64% … assigned in a 2:1:1 ratio to receive 3 mg liraglutide, 1.8 mg liraglutide, or placebo.49 After 56 weeks … /m2:49 The weight loss for people treated with liraglutide 3 mg and liraglutide 1.8 mg after 56 weeks … At 56 weeks, 69% of the prediabetes subgroup treated with liraglutide 3 mg no longer showed signs

269. Surveillance & Identification of Triggers for Updating Systematic Reviews for the EHC Program (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer_surveillance.pdf
     August 01, 2012 - CRT (2DRT) Grade 3 dysphagia 57% vs. 58% Time of onset of grade 3 dysphagia 6.4 vs. 4.8 weeks … ; p = 0.05 Duration grade 3 dysphagia toxicity 4.9 vs. 7.5 weeks; p = 0.03 … Conventional RT(2DRT) Grade 3 dysphagia 57% vs. 58% Time of onset of grade 3 dysphagia 6.4 vs. 4.8 weeks … ; p = 0.05 Duration grade 3 dysphagia toxicity 4.9 vs. 7.5 weeks; p = 0.03 Clavel, 2012 7 Non

270. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/undescended-testicle_research-protocol.pdf
     September 02, 2011 - Research and Quality’s Effective Health Care Program Web site for public comment for approximately 4 weeks … later treatment, hormones, and different surgical techniques Outcomes: Immediate (within 6 weeks … of therapy) and short-term (6 weeks to 2 years of therapy) outcomes: 1.

271. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/substanceabuse_hi_impact.pdf
     January 01, 2012 - problems of low adherence and medication diversion, because the drugs’ effects may last for several weeks … problems of low adherence and medication diversion, because the drugs’ effects may last for several weeks … extended-release naltrexone for opioid dependence is intended to be dosed at 380 mg intramuscularly every 4 weeks

272. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - After 24 weeks of treatment, 54% of patients treated with teduglutide were able to reduce the number … Treatment response (defined as least 20% reduction in PN or intravenous volume from baseline to weeks … week reduction in PN support versus a 0.9 liter per week reduction for patients given placebo at 24 weeks … uncontrolled extension of the second trial, patients (n=65) received teduglutide for up to an additional 28 weeks … used to increase nutrient absorption; however, somatropin has not been evaluated for longer than 4 weeks

273. Interventions for Breathlessness in Patients With Advanced Cancer: Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/dyspnea-advanced-cancer-summary-1.pdf
     November 01, 2020 - Walling AM, Weeks JC, Kahn KL, et al. Symptom prevalence in lung and colorectal cancer patients.

274. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update--Executive Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/antipsychotics-children-update_executive.pdf
     January 01, 2018 - Most studies had treatment durations between 4 and 12 weeks; nine studies were 6 months or longer. … Sixteen trials had followup periods ranging from 3 to 12 weeks. … One trial had a controlled extension phase of 30 weeks, one trial had a placebo-controlled maintenance … treatment duration of 72 weeks, and an observational study reviewed charts for between 7 to 8 months … Treatment duration varied widely across studies (range, 4 weeks to 2.3 years).

275. Treatment for Restless Legs Syndrome Disposition of Comments Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_disposition-comments.pdf
     November 27, 2012 - or usual care” to read “the majority of randomized, controlled trials were of short duration (<12 weeks

276. Fraenkel (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/fraenkel.pdf
     May 29, 2025 - Fraenkel Slide 1: Quantifying  Patient Preferences Liana Fraenkel, MD, MPH Associate Professor of Medicine Yale University  School  of Medicine,  New  Haven,  CT Slide 2: Elicitation vs  Construction • Patients frequently do not have preformed  …

277. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-adult-treatment_research-protocol.pdf
     December 20, 2011 - searches to be updated after draft report goes out for peer review Study duration At least 4 weeks … • Interviewees are asked about symptoms they have experienced in the past 2 weeks.

278. high-cholesterol-medicines-update-protocol-130516 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/high-cholestorol-medicines-update_research-protocol.pdf
     December 31, 2013 - trial (RCT) of any duration o Nonrandomized study (NRS) if it is a continuation of an RCT, is over 24 weeks … Other observational designs and Timing • NRS if it is a continuation or extension of an RCT over 24 weeks … reviews) • Published only as abstracts • Indirect comparisons • Crossover trials with fewer than 4 weeks … We will include extensions of RCTs of over 24 weeks, as these will provide long-term followup of a trial … The previous CER considered any NRS over 24 weeks in duration.

279. Menopause Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_executive.pdf
     March 01, 2015 - included randomized controlled trials (RCTs) with 25 or more participants per arm and a followup of 4 weeks … or longer for centrally acting agents and 12 weeks for all other therapies. … testosterone through a patch) compared with placebo—slightly more than one extra episode reported every 4 weeks … , global 10 Estrogen route a vs. route b Not estimated Moderate Activity (higher is better) SSE/4 weeks … aNumber of satisfying sexual episodes per four weeks Urogenital Atrophy One-quarter of trials reported

280. Mindfulness-Based Interventions for Wellbeing and Mental Health in Children and Adolescents: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ped-mindfulness-protocol-amendment.pdf
     February 05, 2025 - • Psychological flexibility (e.g., AFQ-Y, AAQ) • Healthcare utilization Timing • A minimum of 4 weeks … report outcomes at various time points, which we will aggregate into the following intervals: 4 to <8 weeks … , 8 to <12 weeks, 12 weeks to <6 months, 6 months to <12 months, and ≥12 months since the beginning